Abstract
Ebola is one of the most frightening diseases of the modern era. The Ebola virus was discovered in 1976 when two separate species of Ebola caused outbreaks in Zaire and Sudan. Since then, several additional Ebola species have been identified. Ebola is contagious, highly fatal, and incurable. Zaire ebolavirus is the most dangerous species in the group. It has a fatality rate of up to 90%. The initial symptoms of Ebola are non-specific. This makes it very difficult to clinically diagnose Ebola, especially in countries with numerous endemic diseases. Laboratory tests can identify Ebola, but standard RT-PCR tests can take several days to conduct. There is no specific treatment for Ebola. Supportive care is used to assist patients. Several potential drug candidates are available, but none has been approved for general use. Many survivors experience long-term effects from the disease. Some body fluids, especially the semen, can remain Ebola RNA-positive for years after a person has recovered. This book presents a day-by-day account of the 2013–2016 Zaire ebolavirus outbreak. It provides a detailed case study of one of the most significant disease events of the early twenty-first century.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bah EI, Lamah MC, Fletcher T et al (2015) Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 372:40–47
Baize S, Pannetier D, Oestereich L et al (2014) Emergence of Zaire Ebola virus disease in Guinea – preliminary report. N Engl J Med 371:1418–1425
Berlinger J (2016) Ebola vaccine gives 100% protection, study finds. CNN. http://www.cnn.com/2016/12/22/health/ebola-vaccine-study/index.html. Accessed 24 Nov 2017
Boseley S (2015) WHO approves 15-minute test for Ebola. The Guardian. http://www.theguardian.com/world/2015/feb/20/who-approves-15-minute-test-for-ebola. Accessed 20 Feb 2015
Carod-Artal FJ (2015) Post-Ebolavirus disease syndrome: what do we know? Expert Rev Anti-Infect Ther 13:1185–1187
Centers for Disease Control and Prevention (2015) Ebola (Ebola virus disease) – treatment. 22 Jul 2015
Chertow DS, Kleine C, Edwards JK et al (2014) Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med 371:2054–2057
Christie A, Davies-Wayne GJ, Cordier-Lassalle T et al (2015) Possible sexual transmission of Ebola virus-Liberia. MMWR Morb Mortal Wkly Rep 64:479–481
Deen GF, Knust B, Broutet N et al (2017) Ebola RNA persistence in semen of Ebola virus disease survivors—preliminary report. N Engl J Med 377:1428–1437
Epstein L, Wong KK, Kallen AJ et al (2015) Post-Ebola signs and symptoms in US survivors. N Engl J Med 373:2484–2486
Fischer WA, Brown J, Wohl DA et al (2017) Ebola virus ribonucleic acid detection in semen more than two years after resolution of acute Ebola virus infection. In: Open forum infectious diseases, vol 4, no 3. Oxford University Press
Georges AJ, Leroy EM, Renaut AA et al (1999) Ebola hemorrhagic fever outbreaks in Gabon, 1994–1997: epidemiologic and health control issues. J Infect Dis 179(Supplement_1):S65–S75
Grard G, Biek R, Muyembe Tamfum JJ et al (2011) Emergence of divergent Zaire ebola virus strains in Democratic Republic of the Congo in 2007 and 2008. J Infect Dis 204(Supplement_3):S776–S784
Gupta S, Dellorto D (2014) Experimental drug likely saved Ebola patients. CNN. http://www.cnn.com/2014/08/04/health/experimental-ebola-serum/. Accessed 13 Jan 2017
Haaskjold YL, Bolkan HA, Krogh KØ et al (2016) Clinical features of and risk factors for fatal Ebola virus disease, Moyamba District, Sierra Leone, December 2014–February 2015. Emerg Infect Dis 22:1537–1544
Hayman DT, Yu M, Crameri G et al (2012) Ebola virus antibodies in fruit bats, Ghana, West Africa. Emerg Infect Dis 18:1207–1209
Henao-Restrepo AM, Camacho A, Longini IM et al (2017) Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 389:505–518
Howlett P, Walder A, Lisk D et al (2017) Neurological and psychiatric manifestations of post Ebola syndrome in Sierra Leone. Lancet 389:S48
International Committee on Taxonomy of Viruses (2016) Family: Filoviridae. https://talk.ictvonline.org/ictv-reports/ictv_9th_report/negative-sense-rna-viruses-2011/w/negrna_viruses/197/filoviridae. Accessed 23 Oct 2017
International Study Team (1978) Ebola hemorrhagic fever in Zaire, 1976. Bull WHO 56:271–293
Jacobs M, Rodger A, Bell DJ et al (2016) Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 388:498–503
Jagadesh S, Sevalie S, Fatoma R et al (2017) Disability among Ebola survivors and their close contacts in Sierra Leone: a retrospective case-controlled cohort study. Clin Infect Dis 66:131–133
Khan AS, Tshioko FK, Heymann DL et al (1999) The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 179(Supplement_1):S76–S86
Kuhn JH (2008) Filoviruses; a compendium of 40 years of epidemiological, clinical, and laboratory studies. Springer-Verlag/Wien, New York
Lado M, Walker NF, Baker P et al (2015) Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis 15:1024–1033
Leendertz SA, Gogarten JF, Düx A et al (2016) Assessing the evidence supporting fruit bats as the primary reservoirs for Ebola viruses. EcoHealth 13:18–25
Leroy EM, Kumulungui B, Pourrut X et al (2005) Fruit bats as reservoirs of Ebola virus. Nature 438:575–576
Leroy EM, Epelboin A, Mondonge V et al (2009) Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis 9:723–728
MacNeil A, Farnon EC, Wamala J et al (2010) Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis 16:1969–1972
Mupapa K, Massamba M, Kibadi K et al (1999) Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis 179(Suppl 1):S18–S23
Muyembe-Tamfum JJ, Kipasa M, Kiyungu C et al (1999) Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis 179(Supplement_1):S259–S262
Olson PE, Hames CS, Benenson AS et al (1996) The Thucydides syndrome: Ebola deja vu? (or Ebola reemergent?). Emerg Infect Dis 2:155–156
Osterholm MT, Moore KA, Kelley NS et al (2015) Transmission of Ebola viruses: what we know and what we do not know. MBio 6:e00137–e00115
Preston R (1994) The hot zone. Random House, New York
ProMED-mail (2007) Ebola hemorrhagic fever – Congo DR, 21 Nov 2007. http://www.promedmail.org/pls/apex/f?p52400:1000. Accessed 24 Oct 2017
ReliefWeb (2008) Glossary of humanitarian terms. http://www.who.int/hac/about/reliefweb-aug2008.pdf?ua=1. Accessed 27 Oct 2017
Rouquet P, Froment JM, Bermejo M et al (2005) Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001–2003. Emerg Infect Dis 11:283–290
Saéz AM, Weiss S, Nowak K et al (2015) Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol Med 7:17–23
Scarrow GD (1988) The Athenian plague: a possible diagnosis. Anc Hist Bull 2:4–8
Schieffelin JS, Shaffer JG, Goba A et al (2014) Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 371:2092–2100
Sow MS, Etard JF, Baize S et al (2016) New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors. J Infect Dis 214:1475–1476
Thorson A, Formenty P, Lofthouse C et al (2016) Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations. BMJ Open 6:e008859
Towner JS, Rollin PE, Bausch DG et al (2004) Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78:4330–4341
Van Griensven J, Edwards T, De Lamballerie X et al (2016) Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med 374:33–42
Varkey JB, Shantha JG, Crozier I et al (2015) Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 372:2423–2427
World Health Organization (2003) Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001–July 2002. Wkly Epidemiol Rec 78:223–228
World Health Organization (2004) Ebola haemorrhagic fever in the Republic of the Congo – update 6. 6 Jan 2004
World Health Organization (2009) End of Ebola outbreak in the Democratic Republic of the Congo. 17 Feb 2009
World Health Organization (2010) What is a pandemic? 24 Feb 2010
World Health Organization (2014) Case definition recommendations for Ebola or Marburg Virus Diseases. 9 Aug 2014
World Health Organization (2015). World on the verge of an effective Ebola vaccine. 31 Jul 2015
World Health Organization (2016) Interim advice on the sexual transmission of the Ebola virus disease. 21 Jan 2016
World Health Organization (2017) Ebola virus disease. June 2017
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bullard, S.G. (2018). Introduction. In: A Day-by-Day Chronicle of the 2013-2016 Ebola Outbreak. Springer, Cham. https://doi.org/10.1007/978-3-319-76565-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-76565-5_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-76564-8
Online ISBN: 978-3-319-76565-5
eBook Packages: MedicineMedicine (R0)